Thromboembolism Prevention in the PALTC Setting
Thromboembolism Prevention in the PALTC Setting is organized by AMDA - The Society for Post-Acute and Long-Term care Medicine
Activity Created 3/2021
Credits Available Until 3/2024
Description:
Anticoagulation in the PALTC population is challenging, with there being little guidance from the guidelines for the prevention of deep venous thrombosis (DVT). The hospital-based practice has focused on standardized approaches in the evaluation of DVT risk and the application of DVT prevention strategies. Unfortunately, there has been little guidance for prevention in the PALTC environment. This session will review current literature regarding the prevention of thromboembolic disease and will examine risk/benefit analyses for the application of DVT prophylaxis. The hyper-coagulable state of COVID-19 patients will be discussed, as will the importance of thromboembolic disease prevention strategies.
Learning Objectives:
• Develop an evidence-based preventative strategy for your patients.
• Increase awareness of patients at risk for thromboembolic disease.
• Explain the current pharmacologic strategies for the prevention of thromboembolic disease.
• Describe the importance of thromboembolism prevention in COVID-19.